Literature DB >> 22659308

Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.

Chang-Hyun Song1, Xueliang Fan, Cicely J Exeter, Ellen J Hess, H A Jinnah.   

Abstract

The dystonias are a group of disorders characterized by involuntary twisting movements and abnormal posturing. The most common of the inherited dystonias is DYT1 dystonia, which is due to deletion of a single GAG codon (ΔE) in the TOR1A gene that encodes torsinA. Since some forms of dystonia have been linked with dysfunction of brain dopamine pathways, the integrity of these pathways was explored in a knock-in mouse model of DYT1 dystonia. In DYT1(ΔE) knock-in mice, neurochemical measures revealed only small changes in the content of dopamine or its metabolites in tissue homogenates from caudoputamen or midbrain, but microdialysis studies revealed robust decreases in baseline and amphetamine-stimulated extracellular dopamine in the caudoputamen. Quantitative stereological methods revealed no evidence for striatal or midbrain atrophy, but substantia nigra neurons immunopositive for tyrosine hydroxylase were slightly reduced in numbers and enlarged in size. Behavioral studies revealed subtle abnormalities in gross motor activity and motor coordination without overt dystonia. Neuropharmacological challenges of dopamine systems revealed normal behavioral responses to amphetamine and a minor increase in sensitivity to haloperidol. These results demonstrate that this DYT1(ΔE) knock-in mouse model of dystonia harbors neurochemical and structural changes of the dopamine pathways, as well as motor abnormalities.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659308      PMCID: PMC3498628          DOI: 10.1016/j.nbd.2012.05.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  56 in total

Review 1.  Dysfunction of dopaminergic pathways in dystonia.

Authors:  Joel S Perlmutter; Jonathan W Mink
Journal:  Adv Neurol       Date:  2004

2.  Dopamine transmission in DYT1 dystonia.

Authors:  Sarah J Augood; Z Hollingsworth; David S Albers; Lichuan Yang; Joanne Leung; Xandra O Breakefield; David G Standaert
Journal:  Adv Neurol       Date:  2004

Review 3.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

4.  The motor phenotype of Parkinson's disease in relation to age at onset.

Authors:  Mirdhu M Wickremaratchi; M Duleeka W Knipe; B S Dwarakanath Sastry; Elizabeth Morgan; Anne Jones; Rachel Salmon; Richard Weiser; Maralyn Moran; Debbie Davies; Louise Ebenezer; Sandip Raha; Neil P Robertson; Christopher C Butler; Yoav Ben-Shlomo; Huw R Morris
Journal:  Mov Disord       Date:  2011-01-12       Impact factor: 10.338

5.  Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

Authors:  Jasper E Visser; Doug W Smith; Sheryl S Moy; George R Breese; Theodore Friedmann; Jeffrey D Rothstein; H A Jinnah
Journal:  Brain Res Dev Brain Res       Date:  2002-02-28

6.  Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Yuqing Li
Journal:  Behav Brain Res       Date:  2012-02-25       Impact factor: 3.332

7.  Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice.

Authors:  Aziz M Uluğ; An Vo; Miklos Argyelan; Lauren Tanabe; Wynne K Schiffer; Stephen Dewey; William T Dauer; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

8.  An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Chad C Cheetham; Jun Lu; Viet Vo; David M Lovinger; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-08       Impact factor: 3.332

9.  TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion.

Authors:  Kevin Rostasy; Sarah J Augood; Jeffrey W Hewett; Joanne Chung-on Leung; Hikaru Sasaki; Laurie J Ozelius; Vijaya Ramesh; David G Standaert; Xandra O Breakefield; John C Hedreen
Journal:  Neurobiol Dis       Date:  2003-02       Impact factor: 5.996

10.  Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Jianyong Li; David G Standaert; Yuqing Li
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

View more
  51 in total

1.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

Review 3.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

4.  Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Janneth Oleas; Hong Xing; Yuning Liu; Kelly M Dexter; Carly Misztal; Melinda Gerard; Iakov Efimenko; Patrick Lynch; Matthew Villanueva; Raul Alsina; Shiv Krishnaswamy; David E Vaillancourt; Yuqing Li
Journal:  Neurobiol Dis       Date:  2019-10-13       Impact factor: 5.996

5.  Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.

Authors:  Patricia Di Ciano; Daniel F Manvich; Abhiram Pushparaj; Andrew Gappasov; Ellen J Hess; David Weinshenker; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2017-10-30       Impact factor: 4.530

6.  Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia.

Authors:  Chang-Hyun Song; Doug Bernhard; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

7.  Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments.

Authors:  C S Lambert; R M Philpot; M E Engberg; B E Johns; L Wecker
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

8.  Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.

Authors:  Mark P DeAndrade; Amy Trongnetrpunya; Fumiaki Yokoi; Chad C Cheetham; Ning Peng; J Michael Wyss; Mingzhou Ding; Yuqing Li
Journal:  Mov Disord       Date:  2016-05-31       Impact factor: 10.338

9.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

10.  Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Christine Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2019-01-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.